| European Case Law Identifier: | ECLI:EP:BA:1998:T049894.19980622 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 22 June 1998 | ||||||||
| Case number: | T 0498/94 | ||||||||
| Application number: | 81300047.8 | ||||||||
| IPC class: | C12P 1/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: | 
  | 
||||||||
| Title of application: | Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods | ||||||||
| Applicant name: | Ortho Pharmaceutical Corporation | ||||||||
| Opponent name: | Behringwerke Aktiengesellschaft Novartis Patent- und Markenabteilung Boehringer Mannheim GmbH Patentabteilung Becton, Dickinson and Company F. Hoffmann-La Roche & Co. Aktiengesellschaft  | 
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | 
  | 
||||||||
| Keywords: | Sufficiency of disclosure - (no) Inventive step (no)  | 
||||||||
| Catchwords: | 
 -  | 
||||||||
| Cited decisions: | 
  | 
||||||||
| Citing decisions: | 
  | 
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t940498eu1.html
Date retrieved: 17 May 2021
